Key benefits
Hexarelin (examorelin) is a synthetic hexapeptide in the growth hormone releasing peptide (GHRP) family, studied for growth hormone release through ghrelin receptor activation.
Compare research vendor listings by vial size, price per mg and batch COAs on Peptide Grading.
Regulatory activity
Phase I–II Clinical Trials
Early-stage human trials
Route
Subcutaneous
Often studied away from meals; timing varies by protocol.
Cycle
8-16 weeks Typical duration
Storage
Keep cool and dry; refrigerate reconstituted material at 2–8°C.
Follow vendor guidance
Marketplace
Prices per size, coupon codes, lab reports and shipping.
| Vendor | Price | Coupon | Lab test | Shipping | |
|---|---|---|---|---|---|
 Vantage Aminos 2 mg | $30.00 Lowest price$15.00/mg | Not on file | 2-days
| Buy | |
Pure Bio Labs 5 mg | $49.99 $10.00/mg | No code | 1 COA | 2–4 days
| Buy |
 Pure Peptides 5 mg | $50.00 $10.00/mg | 1 COA | 2–3 days
| Buy | |
Blank Peptides 10 mg | $65.00 $6.50/mg | Not on file | 2–3 days
| Buy | |
 Sparta Labs 5 mg | $70.00 $14.00/mg | Not on file | 2–5 days
| Buy | |
$79.99 $16.00/mg | Not on file | 1–4 business days after dispatch
| Buy | ||
Vitality Chems 5 mg | $81.99 $16.40/mg | Not on file | Ships from US fulfillment within 5 business days of payment; 2–5 business days transit
| Buy |
5 mg · Ships from US fulfillment within 5 business days of payment; 2–5 business days transit
$81.99
What the research reports
What published research has reported so far. These are research findings, not promised results, and most come from settings very different from research-grade use.
Potent GH release
Studied for heart protection
Stronger with GHRH
Hexarelin was studied in humans in the 1990s, mostly in short hormone-response tests. Its GH effect weakens with repeated dosing (tachyphylaxis).
Heart-protection findings come mainly from animal studies and small short human studies.
Studies
Journal of Clinical Endocrinology & Metabolism, 1994. Early human study showing dose-dependent GH release by several routes.
View on PubMedCirculation Research, 2002. Identified CD36 as the heart receptor through which hexarelin and related peptides act, in animal studies.
View on PubMedIt is not FDA-approved and is not eligible for routine pharmacy compounding.
It raises cortisol and prolactin as well as GH, and its effect fades with repeated use. Short-term studies report flushing, headache, injection-site reactions and water retention. Raising GH and IGF-1 can reduce insulin sensitivity and raise blood sugar, and long-term effects of keeping IGF-1 elevated, including on cancer risk, are not established. It is prohibited in sport at all times under the WADA list (S2 peptide hormones and growth factors).
Research-grade material sold online is not an approved drug. Its identity, purity and amount can't be assumed without independent testing, so check the vendor's batch COA.
Pairing
GHRH analog + ghrelin mimetic
GHRH analogs (sermorelin, CJC-1295, tesamorelin) and ghrelin-receptor agonists (ipamorelin, GHRP-2, hexarelin) act on different pituitary receptors, and studies show their GH release adds together. That synergy is the reason they're often paired, but no trial has tested the long-term safety of combining them.
Another drug from the same group
Two GHRH analogs, or two ghrelin mimetics, compete for the same receptor. Stacking them adds side effects without clear extra effect.
Diabetes medicines
Higher GH and IGF-1 levels reduce insulin sensitivity, so hexarelin can raise blood sugar and change how well diabetes medicines work.
Glucocorticoids
Raising GH can speed up cortisol clearance. People on steroid replacement for adrenal insufficiency may need their dose reviewed.
FAQ
Listings on Pepgrade are educational and marketplace context. Follow local rules and vendor labeling (e.g. RUO).
Peptide Grading
United States
Australia